North America Metabolomics Market Forecast 2019-2027

North America Metabolomics Market Forecast 2019-2027

KEY FINDINGS
The North America region with regard to the metabolomics market is projected to record growth at a CAGR of 11.62% during the projected period. The increasing adoption of metabolomics across the medical sectors of the region is one of the most important drivers of market growth.

MARKET INSIGHTS
The metabolomics market in the North American region is studied through the market regions of Canada and the United States. The large presence of the major manufacturers in the metabolomics market of the region, have resulted in innovations in the domain of metabolomics. In the US region, metabolomics finds its applications in the study of metabolic processes and fundamental metabolic alterations in disease onset. The metabolomics also finds immense use in the pharmaceutical industry, where it is used as a tool to support improvements in patient care, which, in turn, drives the metabolomics market growth in the US. Further, the adoption of personalized medicine is increasing every year, and the wide-scale utilization of the metabolomics for personalized medicine is aiding the market growth. The United States is considered to be the largest biopharmaceutical market. The applications of metabolomics in the Canadian region is resulting in many biomarkers discoveries, thereby improving the screening methods. This factor helps the medical setting of the region, thereby augmenting the growth of the metabolomics market.

COMPETITIVE INSIGHTS
The well-established players in the market include, Shimadzu Corporation, Agilent Technologies, Inc., Apical Scientific Sdn Bhd, Human Metabolome Technologies, Inc., Metabolon Inc., Leco Corporation, Perkinelmer, Inc., Kore Technology Limited, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top-down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Metabolomics Bioinformatics Tools And Services Are The Fastest Growing Product & Service
3.2.2. Biomarker Discovery Is The Widely Used Application
3.2.3. Cancer Is The Most Prevalent Indication
4. Market Dynamics
4.1. Market Scope & Definition
4.2. Market Drivers
4.2.1. Growing Investments In The Metabolomics Domain By The Public And Private Sectors
4.2.2. Rise In The Demand For Personalized Medicines
4.2.3. Upsurge In The Incidences Of Chronic Disease
4.3. Market Restraints
4.3.1. Lack Of Skilled Professionals In Metabolomics
4.3.2. High Cost Of The Instruments
4.4. Market Opportunities
4.4.1. Emerging Application Of Metabolomics In Human Nutrition
4.4.2. Growing Usages In The Early Detection Of Chronic Diseases
4.5. Market Challenges
4.5.1. Complex And Diverse Nature Of The Biological Samples
5. Market By Product & Service
5.1. Metabolomics Instruments
5.1.1. Separation Technique
5.1.2. Detection Technique
5.2. Metabolomics Bioinformatics Tools And Services
6. Market By Application
6.1. Biomarker Discovery
6.2. Drug Discovery
6.3. Toxicology Testing
6.4. Nutrigenomics
6.5. Functional Genomics
6.6. Personalized Medicine
6.7. Other Application
7. Market By Indication
7.1. Cancer
7.2. Cardiovascular Disorders
7.3. Neurological Disorders
7.4. Inborn Errors Of Metabolism
7.5. Other Indication
8. Key Analytics
8.1. Porter’s Five Forces Model
8.1.1. Threat Of New Entrants
8.1.2. Threat Of Substitute
8.1.3. Bargaining Power Of Buyers
8.1.4. Bargaining Power Of Suppliers
8.1.5. Threat Of Competitive Rivalry
8.2. Value Chain Analysis
8.3. Market Trends
8.4. Opportunity Matrix
9. Geographical Analysis
9.1. North America
9.1.1. The United States
9.1.2. Canada
10. Competitive Landscape
10.1. Market Position Analysis
10.2. Company Profiles
10.2.1. Agilent Technologies, Inc.
10.2.2. Apical Scientific Sdn Bhd
10.2.3. Biocrates Life Sciences Ag
10.2.4. Bio-rad Laboratories, Inc.
10.2.5. Bruker Corporation
10.2.6. Creative Proteomics
10.2.7. Danaher Corporation (Sciex)
10.2.8. Human Metabolome Technologies, Inc.
10.2.9. Kore Technology Limited
10.2.10. Leco Corporation
10.2.11. Metabolon Inc.
10.2.12. Perkinelmer, Inc.
10.2.13. Shimadzu Corporation
10.2.14. Thermo Fisher Scientific Inc.
10.2.15. Waters Corporation
List Of Tables
Table 1: North America Metabolomics Market, 2019-2027 ($ Million)
Table 2: North America Metagenomics Market, By Product & Service, 2019-2027 ($ Million)
Table 3: North America Metabolomics Instruments Market, 2019-2027 ($ Million)
Table 4: North America Metabolomics Instruments Market, By Type, 2019-2027 ($ Million)
Table 5: North America Separation Technique Market, 2019-2027 ($ Million)
Table 6: North America Detection Technique Market, 2019-2027 ($ Million)
Table 7: North America Metabolomics Bioinformatics Tools And Services Market, 2019-2027 ($ Million)
Table 8: North America Metabolomics Market, By Application, 2019-2027 ($ Million)
Table 9: North America Biomarker Discovery Market, 2019-2027 ($ Million)
Table 10: North America Drug Discovery Market, 2019-2027 ($ Million)
Table 11: North America Toxicology Testing Market, 2019-2027 ($ Million)
Table 12: North America Nutrigenomics Market, 2019-2027 ($ Million)
Table 13: North America Functional Genomics Market, 2019-2027 ($ Million)
Table 14: North America Personalized Medicine Market, 2019-2027 ($ Million)
Table 15: North America Other Application Market, 2019-2027 ($ Million)
Table 16: North America Metabolomics Market, By Indication, 2019-2027 ($ Million)
Table 17: North America Cancer Market, 2019-2027 ($ Million)
Table 18: North America Cardiovascular Disorders Market, 2019-2027 ($ Million)
Table 19: North America Neurological Disorders Market, 2019-2027 ($ Million)
Table 20: North America Inborn Errors Of Metabolism Market, 2019-2027 ($ Million)
Table 21: North America Other Indication Market, 2019-2027 ($ Million)
Table 22: North America Metabolomics Market, By Country, 2019-2027 ($ Million)
Table 23: The United States Metabolomics Market, By Product & Service, 2019-2027 ($ Million)
Table 24: The United States Metabolomics Market, By Application, 2019-2027 ($ Million)
Table 25: The United States Metabolomics Market, By Indication, 2019-2027 ($ Million)
Table 26: Canada Metabolomics Market, By Product & Service, 2019-2027 ($ Million)
Table 27: Canada Metabolomics Market, By Application, 2019-2027 ($ Million)
Table 28: Canada Metabolomics Market, By Indication, 2019-2027 ($ Million)
Table 29: Metabolomics Company Market Position Analysis, 2018
List Of Figures
Figure 1: North America Metabolomics Market, 2019-2027 ($ Million)
Figure 2: North America Metagenomics Market, By Metabolomics Instruments, 2019-2027 ($ Million)
Figure 3: North America Metabolomics Instruments Market, By Separation Technique, 2019-2027 ($ Million)
Figure 4: North America Metabolomics Instruments Market, By Detection Technique, 2019-2027 ($ Million)
Figure 5: North America Metagenomics Market, By Metabolomics Bioinformatics Tools And Services, 2019-2027 ($ Million)
Figure 6: North America Metabolomics Market, By Biomarker Discovery, 2019-2027 ($ Million)
Figure 7: North America Metabolomics Market, By Drug Discovery, 2019-2027 ($ Million)
Figure 8: North America Metabolomics Market, By Toxicology Testing, 2019-2027 ($ Million)
Figure 9: North America Metabolomics Market, By Nutrigenomics, 2019-2027 ($ Million)
Figure 10: North America Metabolomics Market, By Functional Genomics, 2019-2027 ($ Million)
Figure 11: North America Metabolomics Market, By Personalized Medicine, 2019-2027 ($ Million)
Figure 12: North America Metabolomics Market, By Other Application, 2019-2027 ($ Million)
Figure 13: North America Metabolomics Market, By Cancer, 2019-2027 ($ Million)
Figure 14: North America Metabolomics Market, By Cardiovascular Disorders, 2019-2027 ($ Million)
Figure 15: North America Metabolomics Market, By Neurological Disorders, 2019-2027 ($ Million)
Figure 16: North America Metabolomics Market, By Inborn Errors Of Metabolism, 2019-2027 ($ Million)
Figure 17: North America Metabolomics Market, By Other Indication, 2019-2027 ($ Million)
Figure 18: Porter’s Five Force Model
Figure 19: The United States Metabolomicsmarket, 2019-2027 ($ Million)
Figure 20: Canada Metabolomics Market, 2019-2027 ($ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook